Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Purine nucleoside analogs are synthetic molecules structurally similar to natural purine nucleosides. They act as antimetabolites, disrupting DNA and RNA synthesis by incorporating into nucleic acids and causing chain termination or inhibiting further elongation. These analogs are used as anticancer agents, particularly in hematologic malignancies, and some have immunosuppressive properties.
Inhibition of DNA/RNA synthesis via incorporation, chain termination, and apoptosis induction after intracellular activation (phosphorylation).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Purine Nucleoside Analog.